Skip to main content
DUKE CAPITAL LIMITED logo

DUKE CAPITAL LIMITED — Investor Relations & Filings

Ticker · DUKE ISIN · GG00BYZSSY63 LEI · 213800GUTKPSJ39SER44 IL Financial and insurance activities
Open in API
Filings indexed 304 across all filing types
Latest filing 2023-07-31 Regulatory Filings
Country GG Guernsey
Listing IL DUKE

About DUKE CAPITAL LIMITED

https://www.dukecapital.com

Duke Capital Limited is a provider of hybrid capital solutions for small and medium-sized enterprises (SMEs). The company's financing model combines features of both debt and equity, offering a unique long-term, evergreen capital solution often described as a 'corporate mortgage'. This approach allows business owners to secure funding for events such as management buyouts, buy-and-build strategies, and shareholder restructuring, while retaining majority control and strategic direction. A key feature of Duke's offering is the elimination of refinancing risk and the pressure for a short-term exit, aligning its returns with the long-term success of its partner companies. The firm's investment pillars focus on capital preservation, attractive dividend yield, and providing upside upon exits.

Recent filings

Filing Released Lang Actions
New Royalty Agreement
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 6404H' and concludes with standard RNS disclaimers, indicating it is a regulatory news service announcement from the London Stock Exchange. The content details a specific corporate action: Duke Royalty entering into an US$11.5 million royalty financing agreement with Glasshouse Products, LLC, which facilitates a management buyout. This is a material event announcement concerning financing and partnership, but it is not a full financial report (like 10-K or IR), an earnings release (ER), or a proxy statement. Since it is a specific, material corporate announcement distributed via RNS that doesn't fit the highly specific categories like DIRS, DIV, or CAP (though it relates to financing, it's an announcement of a deal, not a general capital update), the most appropriate general regulatory filing category is RNS, as it is explicitly branded as an RNS release.
2023-07-31 English
Director/PDMR Dealings
Director's Dealing Classification · 99% confidence The document is a regulatory announcement filed via RNS (RNS Number : 4838H) dated July 28, 2023. The content explicitly details 'Director/PDMR Dealings' concerning the grant of Performance Share Awards (PSAs) under the Long-Term Incentive Plan (LTIP) and the vesting of previous PSAs for key executives (Neil Johnson and Charlie Cannon Brookes). This directly corresponds to the definition of reporting personal share transactions by company directors and executives, which maps to the 'Director's Dealing' category.
2023-07-28 English
Follow-On Investment into Existing Royalty Partner
Capital/Financing Update Classification · 99% confidence The document is identified by the 'RNS Number' header and contains a date (20 July 2023) and company information, typical of a regulatory news service announcement. The content describes a specific corporate action: a follow-on investment (£2.80 million) into an existing royalty partner (InTec) to fund an acquisition. This is a material event announcement that does not fit the specific categories like 10-K, ER, or DIV. Since it is a general regulatory announcement provided via RNS and doesn't fit a more specific category like M&A (TAR) or Capital Change (CAP) which usually involve formal offers or share structure changes, the most appropriate general classification for a standard regulatory news service release is RNS.
2023-07-20 English
Final Results for the year ended 31 March 2023
Earnings Release Classification · 95% confidence The document explicitly states it contains the "Final Results for the year ended 31 March 2023" and includes detailed financial highlights, CEO/Chairman statements regarding performance, and mentions that the "Audited final results" are being announced. This strongly indicates a comprehensive annual financial report summary. Furthermore, it mentions that the "2023 Annual Report and Accounts are expected to be posted to shareholders on Monday 10 July 2023," suggesting this announcement is the preliminary release or summary of those results, which aligns best with the Earnings Release (ER) category for key highlights, or potentially the Annual Report (10-K) if it contained the full statutory filing. Given the context of an RNS announcement providing key figures and referencing the forthcoming full Annual Report and Accounts, it functions primarily as an Earnings Release (ER) summarizing the year-end performance. However, since the document is very long (over 120k characters) and contains substantial narrative and detailed financial metrics, it goes beyond a typical brief 'Earnings Release' (ER) and contains the core content that would be in the Annual Report, even if the formal 'Annual Report & Accounts' document is pending posting. Since the text is a detailed summary of the full year's audited results, it is classified as the comprehensive annual report content, which maps to the 10-K definition, even if it's presented via an RNS wrapper. The presence of the Chairman's and CEO's statements covering the entire fiscal year solidifies this as the primary annual performance disclosure. FY 2023
2023-07-04 English
Follow-On Investment into Existing Royalty Partner
Capital/Financing Update Classification · 99% confidence The document begins with an 'RNS Number' and is dated '03 July 2023'. It announces a specific corporate action: a 'Follow-On Investment into Existing Royalty Partner' for £1.9 million to fund an acquisition. This is a timely, material announcement disseminated via the Regulatory News Service (RNS). While it contains financial details (investment amount, yield), its primary function is to report a specific corporate event (financing/capital deployment) rather than being a comprehensive periodic report (like 10-K or IR) or a general transcript. The content strongly aligns with an announcement regarding financing activities or capital structure changes. Given the options, 'Capital/Financing Update' (CAP) is the most specific fit for announcing a new investment/financing deal. Although it is distributed via RNS, CAP is more descriptive than the general RNS fallback.
2023-07-03 English
Follow-On Investment into Existing Royalty Partner
Share Issue/Capital Change Classification · 99% confidence The document begins with an RNS Number and is dated June 26, 2023. It announces a specific corporate action: a follow-on investment of £1.8 million into an existing royalty partner (Tristone Healthcare Limited) to fund an acquisition. This type of announcement, which details financing activities, capital deployment, and specific transaction terms, fits best under the 'Capital/Financing Update' category. Although it is distributed via RNS, the content is highly specific to financing rather than being a general regulatory update or a report announcement. Therefore, 'CAP' is the most appropriate classification.
2023-06-26 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.